National Council of Experts: the place of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus

National Council of Experts: the place of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus

TThe annual increase in the prevalence of type 2 diabetes mellitus emphasizes the relevance of the search for new treatment options, along with necessity for regular review of proven therapeutic solutions. Today, dipeptidyl peptidase-4 inhibitors (DPP-4i, gliptins) are effective and safe hypoglycemi...

Full description

Bibliographic Details
Main Authors: M. V. Shestakova, G. R. Vagapova, O. K. Vikulova, G. R. Galstyan, T. Yu. Demidova, E. N. Dudinskaya, T. P. Kiseleva, A. M. Mkrtumyan, N. A. Petunina, O. N. Tkacheva, V. V. Fadeev, Y. S. Khalimov, E. A. Shestakova
Format: Article
Language:English
Published: Endocrinology Research Centre 2023-12-01
Series:Сахарный диабет
Subjects:
dpp-4 inhibitors
type 2 diabetes mellitus
gliptins
sitagliptin
Online Access:https://www.dia-endojournals.ru/jour/article/view/13110

Internet

https://www.dia-endojournals.ru/jour/article/view/13110

Similar Items